For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov:
This pilot study investigates clinical benefit of four 28-day cycles of sertraline in low-risk MDS patients. Participants will receive 100mg of oral sertraline daily. The study will also evaluate potential associated biological mechanisms of action.
Sat, 05/02/2015 to Thu, 06/01/2017
Bone Marrow Disease(s):
myelodysplastic syndromes (MDS)
Drug: Sertraline Other Name: Zoloft Procedure: Bone Marrow Aspirate/Biopsy